JP Patent

JP6106100B2 — 眼瞼下垂症の非外科的治療用組成物および方法

Assigned to VOOM LLC · Expires 2017-03-29 · 9y expired

What this patent protects

Patent listed against oxymetazoline-hydrochloride.

Drugs covered by this patent

oxymetazoline-hydrochloride (OXYMETAZOLINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP6106100B2
Jurisdiction: JP
Classification: —
Expires: 2017-03-29
Drug substance claim: No
Drug product claim: No
Assignee: VOOM LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.